dQ&A Data Services 2026

The Real Deal

Our diabetes Data Services give you instant access to a large treasure trove of data and insights – based on our own high quality primary research.

We built them to answer the most useful and most important questions for diabetes manufacturers.

They are a one-stop shop for every aspect of diabetes market knowledge.


Meet dQ&A’s 2026 Line Up of Industry Standard Data Services

Subscribe to dQ&A’s extensive trended dataset of patient and physician data - which contains an abundance of valuable insights.

Our data services:

  • Include nine countries (USA, Canada, UK, Germany, France, Italy, Spain, Netherlands, Sweden)
  • Cover numerous diabetes drugs, devices and services
  • Survey tens of thousands of patients and thousands of prescribers each year
  • Are updated continually, is longitudinal and trended
  • Are representative of the patient and prescriber population across many measures
  • Contain a detailed demographic and healthographic census of respondents
  • Cover thousands of individual patient journeys
  • Include rich qualitative information in the form of write-in responses
  • Started in 2010 and have become the industry standard!


dQ&A Data Services: The Most Efficient Way to Keep Your Finger on the Diabetes Market Pulse

You can access this data directly, receive regular curated reports, or request delivery of specific data and insights from our helpful customer service team.

dQ&A Data Services Overview

Description

Value

dQ&A Patient Voice (USA/Canada/EU)

Description

dQ&A regularly tracks a very large, representative sample of real people living with diabetes. We understand their attitudes and behavior concerning drugs, devices and many other products and services.

Value

Gold standard data on market trends, competition, adherence, switching, usage and patient experience.

dQ&A Prescriber Perspectives (USA/Canada/EU)

Description

dQ&A tracks endocrinologists and 'diabetes focused’ primary care physicians to understand trends in prescription behavior across drugs, devices, software and digital health.

Value

Essential data for market share forecasting, anticipating prescribing behavior, competitive assessment, and business strategy.

dQ&A Diabetes Drugs Insights

Description

True trended insights regarding the rise of branded GLP-1s and SGLT-2s. What is actually happening to patients and how is HCP prescribing changing? Incredible depth and detail.

Value

Understand the detailed trends and future implications for your business. Bring clarity to strategic decision making.

dQ&A Type 2 Insulin Insights

Description

A unique research service that unravels the complexities of the lived experiences of thousands of people with type 2 diabetes who take insulin.

Value

Determine the interplay between insulin, oral drugs, injectables, and devices. Understand the diversity of this population and how to drive adherence and outcomes.

dQ&A Health App Atlas (USA/Europe)

Description

An in-depth review of diabetes health app trends, attitudes and behavior in the USA and Europe, using reliable five year trended data from patients and physicians.

Value

Make sense of the diabetes landscape, so that you can develop and refine your digital strategy with confidence and precision.

dQ&A Digital Health Experience

Description

dQ&A data service that tracks in-depth patient experience for top apps in diabetes, along with HCP insights for top health platforms.

Value

Understand trial, engagement and loyalty - and how to overcome barriers to adoption. Learn how app experiences correlate to outcomes. Forecast trends in digital health.

dQ&A Hypoglycemia Insights

Description

Deep statistical insight into how thousands of people taking insulin experience and react to the impact of hypoglycemia on their daily lives.

Value

Learn how to help people better predict, avoid, prevent and correct hypoglycemia. Create more effective glucose lowering treatments.

dQ&A First Look

Description

Syndicated qualitative research that brings new product experiences to life. ‘First Look’ gives unprecedented access to many recently launched diabetes products each year.


Library includes:

  • Medtronic InPen
  • FreeStyle Libre 3
  • Medtronic 780G
  • Tandem Remote Bolus
  • Omnipod 5
  • Lilly Mounjaro
  • iLet Bionic Pancreas
  • Tandem Mobi

Coming soon:

  • Sequel twiist
  • Looper AID
  • Awiqli

Value

Grasp the delivery of functional and emotional benefits. Determine successes, pitfalls and reasons why. Elevate product development and commercial strategy.

Do You Have Questions
About Diabetes Research?

We Have Answers.

This research excerpt is just the tip of the iceberg. dQ&A has decades of experience across the United States, Canada, and Europe. If you drive critical diabetes research decisions in your organization, dQ&A is the diabetes insight partner that can get the answers you need.